Water Vapor Ablation for Prostate Cancer: Long-Term Registry

计划入组 2,500 人 · 首次发布于 2026 年 3 月 6 日

Water Vapor Ablation for Grade Group 3 Prostate Cancer

计划入组 120 人 · 首次发布于 2026 年 6 月 16 日

Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

计划入组 400 人 · 首次发布于 2023 年 1 月 13 日

Water(Activase, Alphanate, Alphanine Sd, Eye Stream, Hiberix, Koate, Nuwiq, Profilnine, Prolastin, Serostim, Thrombate III)

<dd class="col-xl-8 col-md-9 col-sm-8">H₂O</dd>

Water-soluble Taxanes

Water-soluble Vitamin

Rx

Vanquish Oncology, Inc.

United States

R. J. Reynolds Vapor Company

United States

Water Pik, Inc.

United States

Francis Medical Receives FDA Clearance for Vanquish Water Vapor Ablation System for Localized Prostate Cancer

Steam Ablation Shows Promise in Treating Intermediate-Risk Prostate Cancer

FDA Clears Francis Medical's Vanquish Water Vapor System for Intermediate-Risk Prostate Cancer Treatment